Showing results (431-440 of 3,716) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|January 1, 1995
A phase II study of interleukin-2 with and without beta-interferon in the treatment of advanced renal cell carcinomaR S Witte, T Leong, M S Ernstoff, et al.Investigational New Drugs|January 1, 1995
A clinical screening cooperative group phase II evaluation of lobaplatin (ASTA D-19466) in advanced head and neck cancerM Degardin, J P Armand, B Chevallier, et al.Investigational New Drugs|November 18, 2016
A phase 1 study combining the HER3 antibody seribantumab (MM-121) and cetuximab with and without irinotecanJames M Cleary, Autumn J McRee, Geoffrey I Shapiro, et al.Investigational New Drugs|November 1, 1992
Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteriaS Green, G R WeissInvestigational New Drugs|November 1, 1992
Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinomaE S Casper, G K Schwartz, B Johnson, et al.Investigational New Drugs|November 1, 1992
Phase II trial of pirarubicin in the treatment of advanced bladder cancerM Mahjoubi, J Kattan, M Ghosn, et al.Investigational New Drugs|May 4, 2004
Efficacy of novel P-glycoprotein inhibitors to increase the oral uptake of paclitaxel in miceHeleen A Bardelmeijer, Mariët Ouwehand, Jos H Beijnen, et al.Investigational New Drugs|May 4, 2004
In vitro characterization of the biotransformation of thiocoraline, a novel marine anti-cancer drugEsther F A Brandon, Rolf W Sparidans, Irma Meijerman, et al.Investigational New Drugs|May 4, 2004
A phase 1 study of OSI-211 given as an intravenous infusion days 1, 2, and 3 every three weeks in patients with solid cancersK Gelmon, H Hirte, B Fisher, et al.Investigational New Drugs|May 4, 2004
A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: a Southwest Oncology Group StudyRobert P Whitehead, Jacqueline K Benedetti, James L Abbruzzese, et al.Pageof 372